Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.
Thomas E. Starzl Transplantation Institute, University of Pittsburgh, 15213, Pittsburgh, PA, USA.
P
P
Chakrabarti
H Y
HY
Wong
A
A
Toyofuku
V P
VP
Scantlebury
M L
ML
Jordan
C
C
Vivas
A B
AB
Jain
J
J
McCauley
J
J
Johnston
P S
PS
Randhawa
T R
TR
Hakala
R L
RL
Simmons
J J
JJ
Fung
T E
TE
Starzl
R
R
Shapiro
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000008:administration & dosage*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage*; D012044:Regression Analysis; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D016896:Treatment Outcome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011241:Prednisone; D016559:Tacrolimus